Chemoinformaics analysis of dihydroxyagarofuran
| Molecular Weight | 222.372 | nRot | 0 |
| Heavy Atom Molecular Weight | 196.164 | nRig | 14 |
| Exact Molecular Weight | 222.198 | nRing | 3 |
| Solubility: LogS | -3.938 | nHRing | 1 |
| Solubility: LogP | 4.919 | No. of Aliphatic Rings | 3 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 2 |
| Atoms Count | 42 | No. of Aliphatic Hetero Cycles | 1 |
| No. of Heavy Atom | 16 | No. of Aromatic Carbocycles | 0 |
| nHetero | 1 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 2 | No. Saturated Carbocycles | 2 |
| No. of Hydrogen atom | 26 | No. of Saturated Hetero Cycles | 1 |
| No. of Carbon atom | 15 | No. of Saturated Rings | 3 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 1 | No. of Arom Bond | 0 |
| nHA | 1 | APOL | 43.1886 |
| nHD | 0 | BPOL | 27.8194 |
| QED | 0.598 |
| Synth | 5.396 |
| Natural Product Likeliness | 3.082 |
| NR-PPAR-gamma | 0.004 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0.735 |
| Pgp-sub | 0 |
| HIA | 0.004 |
| CACO-2 | -4.632 |
| MDCK | 0.0000186 |
| BBB | 0.137 |
| PPB | 0.946339 |
| VDSS | 1.504 |
| FU | 0.0358704 |
| CYP1A2-inh | 0.136 |
| CYP1A2-sub | 0.642 |
| CYP2c19-inh | 0.249 |
| CYP2c19-sub | 0.938 |
| CYP2c9-inh | 0.226 |
| CYP2c9-sub | 0.226 |
| CYP2d6-inh | 0.064 |
| CYP2d6-sub | 0.331 |
| CYP3a4-inh | 0.596 |
| CYP3a4-sub | 0.551 |
| CL | 12.84 |
| T12 | 0.108 |
| hERG | 0.066 |
| Ames | 0.009 |
| ROA | 0.045 |
| SkinSen | 0.817 |
| Carcinogencity | 0.627 |
| EI | 0.928 |
| Respiratory | 0.951 |
| NR-Aromatase | 0.348 |
| Antiviral | Yes |
| Prediction | 0.861937 |